A citation-based method for searching scientific literature

Sebastian Palmqvist, Michael Schöll, Olof Strandberg, Niklas Mattsson, Erik Stomrud, Henrik Zetterberg, Kaj Blennow, Susan Landau, William Jagust, Oskar Hansson. Nat Commun 2017
Times Cited: 361







List of co-cited articles
787 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Clifford R Jack, David A Bennett, Kaj Blennow, Maria C Carrillo, Billy Dunn, Samantha Budd Haeberlein, David M Holtzman, William Jagust, Frank Jessen, Jason Karlawish,[...]. Alzheimers Dement 2018
38


Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Reisa A Sperling, Paul S Aisen, Laurel A Beckett, David A Bennett, Suzanne Craft, Anne M Fagan, Takeshi Iwatsubo, Clifford R Jack, Jeffrey Kaye, Thomas J Montine,[...]. Alzheimers Dement 2011
20

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.
Clifford R Jack, David S Knopman, William J Jagust, Ronald C Petersen, Michael W Weiner, Paul S Aisen, Leslie M Shaw, Prashanthi Vemuri, Heather J Wiste, Stephen D Weigand,[...]. Lancet Neurol 2013
16

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.
Randall J Bateman, Chengjie Xiong, Tammie L S Benzinger, Anne M Fagan, Alison Goate, Nick C Fox, Daniel S Marcus, Nigel J Cairns, Xianyun Xie, Tyler M Blazey,[...]. N Engl J Med 2012
16

In vivo staging of regional amyloid deposition.
Michel J Grothe, Henryk Barthel, Jorge Sepulcre, Martin Dyrba, Osama Sabri, Stefan J Teipel. Neurology 2017
199
15

Phases of A beta-deposition in the human brain and its relevance for the development of AD.
Dietmar R Thal, Udo Rüb, Mario Orantes, Heiko Braak. Neurology 2002
14

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Guy M McKhann, David S Knopman, Howard Chertkow, Bradley T Hyman, Clifford R Jack, Claudia H Kawas, William E Klunk, Walter J Koroshetz, Jennifer J Manly, Richard Mayeux,[...]. Alzheimers Dement 2011
14

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.
Victor L Villemagne, Samantha Burnham, Pierrick Bourgeat, Belinda Brown, Kathryn A Ellis, Olivier Salvado, Cassandra Szoeke, S Lance Macaulay, Ralph Martins, Paul Maruff,[...]. Lancet Neurol 2013
13


Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.
Randy L Buckner, Abraham Z Snyder, Benjamin J Shannon, Gina LaRossa, Rimmon Sachs, Anthony F Fotenos, Yvette I Sheline, William E Klunk, Chester A Mathis, John C Morris,[...]. J Neurosci 2005
13

The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
William E Klunk, Robert A Koeppe, Julie C Price, Tammie L Benzinger, Michael D Devous, William J Jagust, Keith A Johnson, Chester A Mathis, Davneet Minhas, Michael J Pontecorvo,[...]. Alzheimers Dement 2015
379
13

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
Willemijn J Jansen, Rik Ossenkoppele, Dirk L Knol, Betty M Tijms, Philip Scheltens, Frans R J Verhey, Pieter Jelle Visser, Pauline Aalten, Dag Aarsland, Daniel Alcolea,[...]. JAMA 2015
854
13

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.
Clifford R Jack, David S Knopman, William J Jagust, Leslie M Shaw, Paul S Aisen, Michael W Weiner, Ronald C Petersen, John Q Trojanowski. Lancet Neurol 2010
13

Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
Sylvia Villeneuve, Gil D Rabinovici, Brendan I Cohn-Sheehy, Cindee Madison, Nagehan Ayakta, Pia M Ghosh, Renaud La Joie, Samia Kate Arthur-Bentil, Jacob W Vogel, Shawn M Marks,[...]. Brain 2015
232
11

Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
Clifford R Jack, Heather J Wiste, Stephen D Weigand, Terry M Therneau, Val J Lowe, David S Knopman, Jeffrey L Gunter, Matthew L Senjem, David T Jones, Kejal Kantarci,[...]. Alzheimers Dement 2017
355
11

Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography.
Niklas Mattsson, Sebastian Palmqvist, Erik Stomrud, Jacob Vogel, Oskar Hansson. JAMA Neurol 2019
81
13

In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum.
Hanna Cho, Jae Yong Choi, Mi Song Hwang, You Jin Kim, Hye Mi Lee, Hye Sun Lee, Jae Hoon Lee, Young Hoon Ryu, Myung Sik Lee, Chul Hyoung Lyoo. Ann Neurol 2016
269
10

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest.
Rahul S Desikan, Florent Ségonne, Bruce Fischl, Brian T Quinn, Bradford C Dickerson, Deborah Blacker, Randy L Buckner, Anders M Dale, R Paul Maguire, Bradley T Hyman,[...]. Neuroimage 2006
10

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
Marilyn S Albert, Steven T DeKosky, Dennis Dickson, Bruno Dubois, Howard H Feldman, Nick C Fox, Anthony Gamst, David M Holtzman, William J Jagust, Ronald C Petersen,[...]. Alzheimers Dement 2011
10

Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist, Ruben Smith, Thomas G Beach, Geidy E Serrano, Xiyun Chai, Nicholas K Proctor, Udo Eichenlaub, Henrik Zetterberg,[...]. Nat Med 2020
318
10

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
William E Klunk, Henry Engler, Agneta Nordberg, Yanming Wang, Gunnar Blomqvist, Daniel P Holt, Mats Bergström, Irina Savitcheva, Guo-feng Huang, Sergio Estrada,[...]. Ann Neurol 2004
9

Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging.
Elizabeth C Mormino, Andre Smiljic, Amynta O Hayenga, Susan H Onami, Michael D Greicius, Gil D Rabinovici, Mustafa Janabi, Suzanne L Baker, Irene V Yen, Cindee M Madison,[...]. Cereb Cortex 2011
228
9

PET Imaging of Tau Deposition in the Aging Human Brain.
Michael Schöll, Samuel N Lockhart, Daniel R Schonhaut, James P O'Neil, Mustafa Janabi, Rik Ossenkoppele, Suzanne L Baker, Jacob W Vogel, Jamie Faria, Henry D Schwimmer,[...]. Neuron 2016
611
9

Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults.
Michelle E Farrell, Xi Chen, Melissa M Rundle, Micaela Y Chan, Gagan S Wig, Denise C Park. Neurology 2018
60
15

Subthreshold Amyloid Predicts Tau Deposition in Aging.
Stephanie L Leal, Samuel N Lockhart, Anne Maass, Rachel K Bell, William J Jagust. J Neurosci 2018
76
11

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Thomas K Karikari, Tharick A Pascoal, Nicholas J Ashton, Shorena Janelidze, Andréa Lessa Benedet, Juan Lantero Rodriguez, Mira Chamoun, Melissa Savard, Min Su Kang, Joseph Therriault,[...]. Lancet Neurol 2020
308
9

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI.
Michael D Greicius, Gaurav Srivastava, Allan L Reiss, Vinod Menon. Proc Natl Acad Sci U S A 2004
9

Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Niklas Mattsson, Philip S Insel, Michael Donohue, Susan Landau, William J Jagust, Leslie M Shaw, John Q Trojanowski, Henrik Zetterberg, Kaj Blennow, Michael W Weiner. Brain 2015
164
9



Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease.
Niklas Mattsson-Carlgren, Emelie Andersson, Shorena Janelidze, Rik Ossenkoppele, Philip Insel, Olof Strandberg, Henrik Zetterberg, Howard J Rosen, Gil Rabinovici, Xiyun Chai,[...]. Sci Adv 2020
91
8

Amyloid deposition is associated with impaired default network function in older persons without dementia.
Reisa A Sperling, Peter S Laviolette, Kelly O'Keefe, Jacqueline O'Brien, Dorene M Rentz, Maija Pihlajamaki, Gad Marshall, Bradley T Hyman, Dennis J Selkoe, Trey Hedden,[...]. Neuron 2009
706
8

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.
Bruno Dubois, Howard H Feldman, Claudia Jacova, Harald Hampel, José Luis Molinuevo, Kaj Blennow, Steven T DeKosky, Serge Gauthier, Dennis Selkoe, Randall Bateman,[...]. Lancet Neurol 2014
8

Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
Sebastian Palmqvist, Shorena Janelidze, Yakeel T Quiroz, Henrik Zetterberg, Francisco Lopera, Erik Stomrud, Yi Su, Yinghua Chen, Geidy E Serrano, Antoine Leuzy,[...]. JAMA 2020
286
8


Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease.
Jacob W Vogel, Yasser Iturria-Medina, Olof T Strandberg, Ruben Smith, Elizabeth Levitis, Alan C Evans, Oskar Hansson. Nat Commun 2020
143
8

CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
Oskar Hansson, John Seibyl, Erik Stomrud, Henrik Zetterberg, John Q Trojanowski, Tobias Bittner, Valeria Lifke, Veronika Corradini, Udo Eichenlaub, Richard Batrla,[...]. Alzheimers Dement 2018
264
7

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.
Christopher M Clark, Michael J Pontecorvo, Thomas G Beach, Barry J Bedell, R Edward Coleman, P Murali Doraiswamy, Adam S Fleisher, Eric M Reiman, Marwan N Sabbagh, Carl H Sadowsky,[...]. Lancet Neurol 2012
524
7

High performance plasma amyloid-β biomarkers for Alzheimer's disease.
Akinori Nakamura, Naoki Kaneko, Victor L Villemagne, Takashi Kato, James Doecke, Vincent Doré, Chris Fowler, Qiao-Xin Li, Ralph Martins, Christopher Rowe,[...]. Nature 2018
695
7

Association Between Earliest Amyloid Uptake and Functional Connectivity in Cognitively Unimpaired Elderly.
Andreas Hahn, Tor O Strandberg, Erik Stomrud, Markus Nilsson, Danielle van Westen, Sebastian Palmqvist, Rik Ossenkoppele, Oskar Hansson. Cereb Cortex 2019
22
31

Neuroanatomical spread of amyloid β and tau in Alzheimer's disease: implications for primary prevention.
Philip S Insel, Elizabeth C Mormino, Paul S Aisen, Wesley K Thompson, Michael C Donohue. Brain Commun 2020
35
20

Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology.
Renaud La Joie, Nagehan Ayakta, William W Seeley, Ewa Borys, Adam L Boxer, Charles DeCarli, Vincent Doré, Lea T Grinberg, Eric Huang, Ji-Hye Hwang,[...]. Alzheimers Dement 2019
83
8

Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.
N Tzourio-Mazoyer, B Landeau, D Papathanassiou, F Crivello, O Etard, N Delcroix, B Mazoyer, M Joliot. Neuroimage 2002
7

Cascading network failure across the Alzheimer's disease spectrum.
David T Jones, David S Knopman, Jeffrey L Gunter, Jonathan Graff-Radford, Prashanthi Vemuri, Bradley F Boeve, Ronald C Petersen, Michael W Weiner, Clifford R Jack. Brain 2016
268
7

Neuronal activity regulates the regional vulnerability to amyloid-β deposition.
Adam W Bero, Ping Yan, Jee Hoon Roh, John R Cirrito, Floy R Stewart, Marcus E Raichle, Jin-Moo Lee, David M Holtzman. Nat Neurosci 2011
575
7

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Jeff Sevigny, Ping Chiao, Thierry Bussière, Paul H Weinreb, Leslie Williams, Marcel Maier, Robert Dunstan, Stephen Salloway, Tianle Chen, Yan Ling,[...]. Nature 2016
7

Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
Nicholas J Ashton, Tharick A Pascoal, Thomas K Karikari, Andréa L Benedet, Juan Lantero-Rodriguez, Gunnar Brinkmalm, Anniina Snellman, Michael Schöll, Claire Troakes, Abdul Hye,[...]. Acta Neuropathol 2021
104
7

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.
B Winblad, K Palmer, M Kivipelto, V Jelic, L Fratiglioni, L-O Wahlund, A Nordberg, L Bäckman, M Albert, O Almkvist,[...]. J Intern Med 2004
6

Amyloid deposition, hypometabolism, and longitudinal cognitive decline.
Susan M Landau, Mark A Mintun, Abhinay D Joshi, Robert A Koeppe, Ronald C Petersen, Paul S Aisen, Michael W Weiner, William J Jagust. Ann Neurol 2012
414
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.